Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/2059
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVella, Jacob
dc.contributor.authorDi Giovanni, Giuseppe
dc.date.accessioned2015-03-27T09:35:15Z
dc.date.available2015-03-27T09:35:15Z
dc.date.issued2013
dc.identifier.citationXjenza. 2013, Vol.1(2), p. 72-84en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/2059
dc.description.abstractNicotine, the major psychoactive compound in tobacco, acts as a potent addictive drug in humans. The addictive nature of nicotine leads to more than 6 million deaths a year. Evidence indicates that nicotine and other drugs of abuse act on central dopaminergic pathways and modulate their neurophysiological mechanisms. Nicotine stimulates dopaminergic pathways and the prefrontal cortex (PFC), inducing enhanced reward perception and increased cognitive function, respectively. These findings are consistent with the fact that nicotine binds to different subtypes of nicotinic acetylcholine receptors present on the neurons found in the PFC and ventral tegmental area of the midbrain. The latter, being the area most involved in addictive behaviour, projects on the limbic system, particularly the nucleus accumbens, and receives afferents from the prefrontal cortex and brainstem. Although dopaminergic pathways and nicotinic acetylcholine receptors are the protagonists of nicotine addiction, several minor pathways and their constituent receptors have been indicated as being either directly or indirectly affected by nicotine. These include serotonergic pathways and central cannabinoid receptors. Despite the scarcity of approved drugs and partial efficacy of approved treatment, insight into nicotine neurophysiological modulation led to better appreciation of nicotine-seeking behaviour and subsequent improved design of pharmacological and behavioural approaches to smoking cessation. Tobacco is the single most preventable cause of death in the world today. Better understanding of the neurobiological mechanisms underlying nicotine addiction will ultimately lead to more effective treatments of both nicotine dependence and nicotine rewarding effects.en_GB
dc.language.isoenen_GB
dc.publisherMalta Chamber of Scientistsen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectNicotine addictionen_GB
dc.titleNicotine addiction : a reviewen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.7423/XJENZA.2013.2.09
Appears in Collections:Scholarly Works - FacM&SPB
Xjenza, 2013, Volume 1, Issue 2
Xjenza, 2013, Volume 1, Issue 2

Files in This Item:
File Description SizeFormat 
Nicotine Addiction A Review.pdf1.5 MBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.